| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | Director | Common Stock | 1.06M | $13.7M | $12.93 | Jun 24, 2024 | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust |
| BIODESIX INC | Director | Common Stock | 180K | $221K | $1.23 | Aug 3, 2023 | By The Jon Faiz Kayyem Revocable Trust |
| BIODESIX INC | Director | Common Stock | 177K | $217K | $1.23 | Aug 3, 2023 | Direct |
| Inhibrx Biosciences, Inc. | Director | Common Stock | 16.3K | $210K | $12.93 | Jun 24, 2024 | By Child A |
| Inhibrx Biosciences, Inc. | Director | Common Stock | 16.3K | $210K | $12.93 | Jun 24, 2024 | By Child B |
| BIODESIX INC | Director | Restricted Stock Units | 46.7K | $19.6K | $0.42 | May 21, 2024 | Direct |
| Inhibrx, Inc. | Director | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | By Child A |
| Inhibrx, Inc. | Director | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | By Child B |
| Inhibrx, Inc. | Director | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust |
| Inhibrx, Inc. | Director | Stock Option (right to buy) | 0 | $0 | $34.12 | May 30, 2024 | Direct |
| BIODESIX INC | Director | Stock Options (Right to Buy) | 37.1K | May 21, 2024 | Direct | ||
| Inhibrx Biosciences, Inc. | Director | Stock Option (right to buy) | 30K | May 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | Jun 24, 2024 | 3 | $0 | 4 | Jun 24, 2024 | Director |
| INBX | Inhibrx Biosciences, Inc. | Jun 5, 2024 | 2 | $997K | 4 | Jun 7, 2024 | Director |
| INBX | Inhibrx Biosciences, Inc. | May 31, 2024 | 5 | $4.93M | 4 | Jun 4, 2024 | Director |
| INBX | Inhibrx, Inc. | May 30, 2024 | 7 | -$98.2M | 4 | May 30, 2024 | Director |
| INXB | Inhibrx Biosciences, Inc. | May 29, 2024 | 4 | $0 | 4 | May 30, 2024 | Director |
| INXB | Inhibrx Biosciences, Inc. | May 24, 2024 | 0 | $0 | 3 | May 24, 2024 | Director |
| BDSX | BIODESIX INC | May 21, 2024 | 2 | $0 | 4 | May 23, 2024 | Director |
| BDSX | BIODESIX INC | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Director |
| BDSX | BIODESIX INC | Aug 3, 2023 | 1 | $10K | 4 | Aug 7, 2023 | Director |
| INBX | Inhibrx, Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
| BDSX | BIODESIX INC | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| BDSX | BIODESIX INC | Mar 31, 2023 | 2 | $0 | 4 | Apr 4, 2023 | Director |
| INBX | Inhibrx, Inc. | Jan 23, 2023 | 1 | -$240K | 4 | Jan 23, 2023 | Director |
| BDSX | BIODESIX INC | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| BDSX | BIODESIX INC | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| BDSX | BIODESIX INC | Dec 21, 2022 | 2 | $0 | 4 | Dec 22, 2022 | Director |
| INBX | Inhibrx, Inc. | Dec 21, 2022 | 2 | -$257K | 4 | Dec 22, 2022 | Director |
| INBX | Inhibrx, Inc. | Nov 21, 2022 | 2 | -$284K | 4 | Nov 22, 2022 | Director |
| BDSX | BIODESIX INC | Nov 21, 2022 | 1 | $200K | 4 | Nov 21, 2022 | Director |
| INBX | Inhibrx, Inc. | Oct 21, 2022 | 2 | -$286K | 4 | Oct 24, 2022 | Director |
| INBX | Inhibrx, Inc. | Aug 24, 2022 | 1 | $0 | 4 | Aug 25, 2022 | Director |
| INBX | Inhibrx, Inc. | Aug 5, 2022 | 1 | $0 | 4 | Aug 8, 2022 | Director |
| INBX | Inhibrx, Inc. | Aug 2, 2022 | 3 | $0 | 4 | Aug 2, 2022 | Director |
| INBX | Inhibrx, Inc. | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| BDSX | BIODESIX INC | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| BDSX | BIODESIX INC | Dec 6, 2021 | 3 | $0 | 4 | Dec 8, 2021 | Director |
| BDSX | BIODESIX INC | Dec 6, 2021 | 0 | $0 | 3 | Dec 8, 2021 | Director |
| INBX | Inhibrx, Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |